RE: New blood4 Jul 2021 15:44
Yes, GF. Good post. I'm a LTH and i'm still looking at Sareum through cynical eyes. I always look forwards to RMM's valuations because he shows his working out and puts his arguments across. The last couple of sentences say it all. IF everything works, we will be rich, IF nothing works, we have nothing. The pessimist in me thinks that RMM's counterpart at Pharma x can do the same sums as RMM, probably with more data than RMM and if he/she comes up with the same numbers, why haven't they made an offer at say 30p? 30p would be a massive discount on thise numbers and i'm pretty sure it would get voted through. The answer is data, we need some clinical data and we aren't yet in the clinic. I find it perfectly understandable to be cautious of buying at 7p, i'd be the same. labelling them as wombles isn't the right thing to do.